Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Topics in Current Chemistry|June 2, 2011
Synthesis of 14-alkoxymorphinan derivatives and their pharmacological actionsHelmut Schmidhammer, Mariana SpeteaInternational Journal of Medicinal Chemistry|May 9, 2015
Development of 5-Substituted N-Methylmorphinan-6-ones as Potent Opioid Analgesics with Improved Side-Effect ProfileHelmut Schmidhammer, Mariana SpeteaMolecules (Basel, Switzerland)|September 28, 2021
Recent Chemical and Pharmacological Developments on 14-Oxygenated-N-methylmorphinan-6-onesMariana Spetea, Helmut SchmidhammerMolecules (Basel, Switzerland)|December 4, 2020
Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug DiscoveryMariana Spetea, Helmut SchmidhammerHandbook of Experimental Pharmacology|January 17, 2021
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid LigandsMariana Spetea, Helmut SchmidhammerACS Chemical Neuroscience|January 27, 2017
Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor AgonistsStefan M Noha, Helmut Schmidhammer, Mariana SpeteaMolecules (Basel, Switzerland)|November 5, 2020
Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological ActivitiesHelmut Schmidhammer, Filippo Erli, Elena Guerrieri, et al.Molecules (Basel, Switzerland)|February 15, 2022
Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin ReceptorsKristina Puls, Helmut Schmidhammer, Gerhard Wolber, et al.Neuropharmacology|February 28, 2015
Peripheral μ-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminalsLandon D Baillie, Helmut Schmidhammer, Sean J MulliganCurrent Pharmaceutical Design|March 2, 2013
The µ opioid receptor and ligands acting at the µ opioid receptor, as therapeutics and potential therapeuticsMariana Spetea, Muhammad Faheem Asim, Gerhard Wolber, et al.Pageof 6